This review presents the most up-to-date information regarding available methods, safety, efficacy, and availability of emergency contraception for adolescents.
Recent reanalysis suggests that previously reported efficacy rates for the levonorgestrel-only method emergency contraception were probably overestimated. A newer and more efficacious method of emergency contraception, ulipristal acetate, was FDA approved in August 2010.
Emergency contraception provides young women with an opportunity to prevent pregnancy in the event of unprotected sexual intercourse. Several dedicated products are available commercially in the USA with varying efficacy rates. Barriers, including cost and accessing emergency contraception within the designated time frame, often prevent use among young women.
aUniversity of Illinois at Chicago, School of Medicine, Chicago, Illinois
bPediatrics, Division of Adolescent Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
Correspondence to Melanie A. Gold, D.O., Clinical Professor of Pediatrics, Division of Adolescent Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine, Staff Physician, Division of Student Affairs, University of Pittsburgh Student Health Service, Medical Arts Building, Suite 500, 3708 Fifth Avenue, Pittsburgh, PA 15213, USATel: +1 412 383 1800; fax: +1 412 383 1807; e-mail: firstname.lastname@example.org